Fig. 3From: Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly – a randomised, double-blinded trialNT-proBNP-value at day 0 before and after exercise. There is no significant difference between the Pimobendan-group and the placebo-group (before exercise: p = 0.15, after exercise: p = 0.10)Back to article page